Most cited papers in Breast Lesions and Carcinomas

Breast Lesions and Carcinomas

What are the most cited papers in Breast Lesions and Carcinomas?

The most cited paper in Breast Lesions and Carcinomas is "Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer" (Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al., 2013), with 13,212 citations. Next come "A Gene-Expression Signature as a Predictor of Survival in Breast Cancer" (6,562) and "A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer" (6,414).

Published TypeAccessAuthorsCitations

Showing 50 of 100 papers. Every paper with more than 1,139 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology Open access	2013	13,212
2	A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver et al. · New England Journal of Medicine Open access	18 Dec 2002	6,562
3	A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine Open access	10 Dec 2004	6,414
4	Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer Bernard Fisher, Stewart Anderson, John Bryant et al. · New England Journal of Medicine Open access	16 Oct 2002	6,293
5	pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up C.W. Elston, Ian Ogilvie Ellis · Histopathology	Nov 1991	6,254
6	Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Edward H. Romond et al. · New England Journal of Medicine Open access	20 Oct 2005	5,398
7	Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Mike J Clarke · The Lancet	Dec 2005	5,167
8	Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer Umberto Veronesi, Natale Cascinelli, Luigi Mariani et al. · New England Journal of Medicine Open access	16 Oct 2002	4,479
9	Ki67 expression in breast cancer Mohamed A. Elkablawy, Abdulkader Mohammed Albasri, Rabab Mohammed et al. · Saudi Medical Journal Open access	Feb 2016	4,397
10	Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials S Darby, Paul McGale, Candace R. Correa et al. · The Lancet ReviewOpen access	22 Oct 2011	4,007
11	Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al. · Annals of Oncology Open access	28 Jun 2011	3,932
12	Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study Lisa A. Carey, Charles M. Perou, Chad Livasy et al. · JAMA	6 Jun 2006	3,866
13	Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer Babak Ehteshami Bejnordi et al. · JAMA Open access	12 Dec 2017	3,405
14	Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano · JAMA Open access	8 Feb 2011	2,968
15	Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology Open access	4 Feb 2008	2,948
16	Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer Armando E. Giuliano, Daniel M. Kirgan, Julia Guenther et al. · Annals of Surgery Open access	Sep 1994	2,923
17	Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Stefan Paul Aebi, T. Davidson, Günther Gruber et al. · Annals of Oncology Open access	May 2010	2,861
18	Adjuvant Trastuzumab in HER2-Positive Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access	5 Oct 2011	2,803
19	Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang et al. · The Lancet	Feb 2005	2,723
20	Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology	17 Apr 2012	2,717
21	Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen et al. · Clinical Cancer Research Open access	15 Aug 2004	2,681
22	American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography Debbie Saslow, Carla Boetes, Wylie Burke et al. · CA A Cancer Journal for Clinicians Open access	Mar 2007	2,657
23	Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Soonmyung Paik, Gong Tang, Steven Shak et al. · Journal of Clinical Oncology	23 May 2006	2,599
24	Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy Marie Overgaard, Per Syrak Hansen, Jens Overgaard et al. · New England Journal of Medicine	2 Oct 1997	2,591
25	Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer Donald A. Berry, Kathleen A. Cronin, Sylvia K. Plevritis et al. · New England Journal of Medicine Open access	26 Oct 2005	2,526
26	Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Joseph A. Sparano et al. · New England Journal of Medicine Open access	3 Jun 2018	2,447
27	Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology	10 Dec 2011	2,403
28	Metastatic Behavior of Breast Cancer Subtypes Hagen Fritz Kennecke, Rinat Yerushalmi, Ryan R. Woods et al. · Journal of Clinical Oncology	25 May 2010	2,337
29	Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer Maggie C.U. Cheang, Stephen Chia, David K. Voduc et al. · JNCI Journal of the National Cancer Institute Open access	12 May 2009	2,257
30	A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale et al. · New England Journal of Medicine Open access	6 Aug 2003	2,226
31	Breast imaging reporting and data system (BI-RADS) Laura Liberman, Jennifer H. Menell · Radiologic Clinics of North America	May 2002	2,160
32	Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Albert L. Siu, on behalf of the U.S. Preventive Services Task Force · Annals of Internal Medicine	12 Jan 2016	2,144
33	The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer et al. · Clinical Cancer Research	15 Apr 2007	2,135
34	70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer Fátima Cardoso et al. · New England Journal of Medicine Open access	24 Aug 2016	2,097
35	The Sentinel Node in Breast Cancer — A Multicenter Validation Study David N. Krag, Donald L. Weaver, Takamaru Ashikaga et al. · New England Journal of Medicine Open access	Oct 1998	2,034
36	Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer Shanu Modi et al. · New England Journal of Medicine Open access	11 Dec 2019	2,026
37	Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer Giovanni Ciriello et al. · Cell Open access160 authors	Oct 2015	1,991
38	Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology Open access	Oct 2010	1,949
39	Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening Etta D. Pisano, Constantine A. Gatsonis, Edward R. Hendrick et al. · New England Journal of Medicine Open access	16 Sep 2005	1,945
40	Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy Roman Rouzier, Charles M. Perou, W. Fraser Symmans et al. · Clinical Cancer Research	15 Aug 2005	1,908
41	American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Gary H. Lyman, Armando E. Giuliano, Mark R. Somerfield et al. · Journal of Clinical Oncology Open access	13 Sep 2005	1,902
42	Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer Timothy Joseph Whelan, Jean‐Philippe Pignol, Mark N. Levine et al. · New England Journal of Medicine Open access	10 Feb 2010	1,895
43	Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Mila Donker et al. · The Lancet Oncology Open access	15 Oct 2014	1,891
44	Screening for breast cancer with mammography Peter Christian Gøtzsche, Karsten Juhl Jørgensen · Cochrane Database of Systematic Reviews Open access	4 Jun 2013	1,882
45	Risk Factors for Breast Cancer in Women with Proliferative Breast Disease William D. Dupont, David L. Page · New England Journal of Medicine	17 Jan 1985	1,858
46	Circulating concentrations of insulin-like growth factor I and risk of breast cancer Susan E. Hankinson, Walter Churchill Willett, Graham A. Colditz et al. · The Lancet	May 1998	1,848
47	Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Priya Rastogi, Stewart Anderson, Harry D. Bear et al. · Journal of Clinical Oncology	7 Feb 2008	1,818
48	Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Bernard Fisher, Ashley E. Brown, E.P. Mamounas et al. · Journal of Clinical Oncology	Jul 1997	1,816
49	Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. A. Thomas Stavros, David Thickman, Cindy Rapp et al. · Radiology	Jul 1995	1,785
50	Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer Joseph Ragaz, Stewart M. Jackson, Nhu Le et al. · New England Journal of Medicine Open access	2 Oct 1997	1,770

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.